StreetInsider.com News Articles

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: Swain Judith L

Thu, 04 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260604/26605871.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: Swain Judith L

Thu, 04 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260604/26605871.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: Sullivan Diane E.

Thu, 04 Jun 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260604/26605838.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: Sullivan Diane E.

Thu, 04 Jun 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260604/26605838.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: SOBECKI CHRISTOPHER J

Thu, 04 Jun 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260604/26605825.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: SOBECKI CHRISTOPHER J

Thu, 04 Jun 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260604/26605825.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: BARKER SAM L

Thu, 04 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260604/26605790.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: BARKER SAM L

Thu, 04 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260604/26605790.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: Cheung Ivan

Thu, 04 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260604/26605807.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: Cheung Ivan

Thu, 04 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260604/26605807.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: Amouyal Philippe

Thu, 04 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260604/26605771.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: Amouyal Philippe

Thu, 04 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260604/26605771.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: DEBBANE RAYMOND

Thu, 04 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260604/26605739.html

Form 4 LEXICON PHARMACEUTICALS, For: Jun 03 Filed by: DEBBANE RAYMOND

Thu, 04 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260604/26605739.html

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions

Wed, 03 Jun 2026 08:00:00 -0400

Presentations highlight consistent A1c reductions with sotagliflozin in type 1 diabetes and pharmacokinetics of pilavapadin across renal function groups

THE WOODLANDS, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it will present data from clinical studies of sotagliflozin in Type 1 diabetes (T1D) and pilavapadin in diabetic peripheral neuropathic pain (DPNP) at the American Diabetes Association (ADA) 2026 Scientific Sessions, being held June 5-8 in New Orleans, Louisiana.

“We look forward to engaging with the diabetes community at ADA 2026, as well as sharing additional data from clinical studies

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions

Wed, 03 Jun 2026 08:00:00 -0400

Presentations highlight consistent A1c reductions with sotagliflozin in type 1 diabetes and pharmacokinetics of pilavapadin across renal function groups

“We look forward to engaging with the diabetes community at ADA 2026, as well as sharing additional data from clinical studies

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 08:30:00 -0400

THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at 2:00 p.m. ET in New York City.